05/14/2024 3:05 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024 1:22 PM | BlackRock Inc. (Filed by) Citius Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/30/2024 3:21 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/03/2024 11:15 PM | Citius Pharmaceuticals (Filer)
| Form EFFECT | |
02/23/2024 3:23 PM | Citius Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
02/23/2024 3:18 PM | Citius Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
02/15/2024 7:45 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:18 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 1:08 PM | BlackRock Inc. (Filed by) Citius Pharmaceuticals (Subject)
| Form SC 13G | |
01/23/2024 3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 6:53 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 6:58 AM | Citius Pharmaceuticals (Subject)
| Form 425 | |
10/12/2023 3:15 PM | Citius Pharmaceuticals (Issuer) Mazur Leonard L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:15 PM | Citius Pharmaceuticals (Issuer) Dutia Suren G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:15 PM | Bartushak Jaime (Reporting) Citius Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:15 PM | Citius Pharmaceuticals (Issuer) MCGRATH DENNIS M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:15 PM | Citius Pharmaceuticals (Issuer) Holuka Eugene Myron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:15 PM | Citius Pharmaceuticals (Issuer) HOLUBIAK MYRON Z (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:15 PM | Citius Pharmaceuticals (Issuer) Czuczman Myron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:15 PM | Citius Pharmaceuticals (Issuer) Webb Carol (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/15/2023 3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 8:53 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2023 7:40 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2023 8:25 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2023 3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2023 3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/29/2023 3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |